Select Page

A blood screening tool for detecting mild cognitive impairment and Alzheimer’s disease among community‐dwelling Mexican Americans and non‐Hispanic Whites: A method for increasing representation of diverse populations in clinical research

June 11, 2021 Abstract Introduction Representation of Mexican Americans in Alzheimer’s disease (AD) clinical research has been extremely poor. Methods Data were examined from the ongoing community-based, multi-ethnic Health & Aging Brain among Latino Elders...

Neuropsychological profile of amyloid‐positive versus amyloid‐negative amnestic Mild Cognitive Impairment

May 6, 2021 Introduction Patients diagnosed with amnestic mild cognitive impairment (aMCI) are at high risk of progressing to dementia. It became possible, through the use of biomarkers, to diagnose those patients with aMCI who have Alzheimer’s disease. However,...